Login / Signup
Serum Myostatin at Dialysis Initiation May Predict 1-Year Mortality and Hospitalization.
Midori Sakashita
Yoshifumi Hamasaki
Rikako Oki
Yohei Komaru
Yoshihisa Miyamoto
Teruhiko Yoshida
Ryo Matsuura
Kent Doi
Masaomi Nangaku
Published in:
Nephron (2024)
Serum myostatin concentration at dialysis initiation is inversely associated with adverse outcomes in these dialysis-initiated patients.
Keyphrases
</>
end stage renal disease
chronic kidney disease
peritoneal dialysis
ejection fraction
newly diagnosed
cardiovascular disease
prognostic factors
cardiovascular events
risk factors
type diabetes
patient reported outcomes
patient reported